MCF‐7 is a frequently used breast cancer cell line obtained from a patient with luminal A breast cancer, which is distinguished by the presence of estrogen receptor (ER) and/or progesterone receptor (PR) expression and low levels of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.